However, the correlations between CHI3L2 expression and clinicopathological features, the association with tumor-infiltrating immune cells, the prognostic value of CHI3L2, and its other functions in gliomas are still unknown. This evidence concerns the gene CHI3L2 and central nervous system cancer.